Systems biology analysis of G protein and MAP kinase signaling in yeast

Approximately a third of all drugs act by binding directly to cell surface receptors coupled to G proteins. Other drugs act indirectly on these same pathways, for example, by inhibiting neurotransmitter reuptake or by blocking the inactivation of intracellular second messengers. These drugs have revolutionized the treatment of human disease. However, the complexity of G protein signaling mechanisms has significantly hampered our ability to identify additional new drug targets. Moreover, today's molecular pharmacologists are accustomed to working on narrowly focused problems centered on a single protein or enzymatic process. Here we describe emerging efforts in yeast aimed at identifying proteins and processes that modulate the function of receptors, G proteins and MAP kinase effectors. The scope of these efforts is far more systematic, comprehensive and quantitative than anything attempted previously, and includes integrated approaches in genetics, proteomics and computational biology.

[1]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[2]  D. Koshland,et al.  An amplified sensitivity arising from covalent modification in biological systems. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. K. Chan,et al.  Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones , 1982, Molecular and cellular biology.

[4]  R. K. Chan,et al.  Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones , 1982, Molecular and cellular biology.

[5]  M. Leider Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[6]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[7]  E. Winter,et al.  An osmosensing signal transduction pathway in yeast. , 1993, Science.

[8]  J. Gibbs,et al.  Pharmaceutical research in molecular oncology , 1994, Cell.

[9]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[10]  H. Dohlman,et al.  Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[11]  B. Barrell,et al.  Life with 6000 Genes , 1996, Science.

[12]  J. Thorner,et al.  Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein alpha subunit) , 1996, Molecular and cellular biology.

[13]  Chi-Ying F. Huang,et al.  Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Ota,et al.  Two Protein-tyrosine Phosphatases Inactivate the Osmotic Stress Response Pathway in Yeast by Targeting the Mitogen-activated Protein Kinase, Hog1* , 1997, The Journal of Biological Chemistry.

[15]  E. Nestler,et al.  Regulators of G-Protein Signaling (RGS) Proteins: Region-Specific Expression of Nine Subtypes in Rat Brain , 1997, The Journal of Neuroscience.

[16]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[17]  T. Maeda,et al.  Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases , 1997, Molecular and cellular biology.

[18]  S R Sprang,et al.  G protein mechanisms: insights from structural analysis. , 1997, Annual review of biochemistry.

[19]  H. Dohlman,et al.  Second Site Suppressor Mutations of a GTPase-deficient G-Protein α-Subunit , 1998, The Journal of Biological Chemistry.

[20]  J. Gutkind The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[21]  P B Sigler,et al.  Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Galpha protein pair in yeast. , 1998, Biochemistry.

[22]  Second site suppressor mutations of a GTPase-deficient G-protein alpha-subunit. Selective inhibition of Gbeta gamma-mediated signaling. , 1998, The Journal of biological chemistry.

[23]  S. Fields,et al.  A biochemical genomics approach for identifying genes by the activity of their products. , 1999, Science.

[24]  R. Lefkowitz,et al.  Feedback Regulation of β-Arrestin1 Function by Extracellular Signal-regulated Kinases* , 1999, The Journal of Biological Chemistry.

[25]  Julie A. Pitcher,et al.  Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases* , 1999, The Journal of Biological Chemistry.

[26]  U. Alon,et al.  Robustness in bacterial chemotaxis , 2022 .

[27]  R. Aebersold,et al.  Feedback Phosphorylation of an RGS Protein by MAP Kinase in Yeast* , 1999, The Journal of Biological Chemistry.

[28]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[29]  H. Bourne,et al.  The expanding spectrum of G protein diseases. , 1999, The New England journal of medicine.

[30]  A. Spiegel G Protein Defects in Signal Transduction , 2000, Hormone Research in Paediatrics.

[31]  T. Hughes,et al.  Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. , 2000, Science.

[32]  S. Pattingre,et al.  Erk1/2-dependent Phosphorylation of Gα-interacting Protein Stimulates Its GTPase Accelerating Activity and Autophagy in Human Colon Cancer Cells* , 2000, The Journal of Biological Chemistry.

[33]  B. Kholodenko,et al.  Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. , 2000, European journal of biochemistry.

[34]  J. Doyle,et al.  Robust perfect adaptation in bacterial chemotaxis through integral feedback control. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[36]  W. Sabbagh,et al.  Specificity of MAP kinase signaling in yeast differentiation involves transient versus sustained MAPK activation. , 2001, Molecular cell.

[37]  James E. Ferrell,et al.  Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. , 2001, Chaos.

[38]  J. Thorner,et al.  Regulation of G protein-initiated signal transduction in yeast: paradigms and principles. , 2001, Annual review of biochemistry.

[39]  Richard R. Neubig,et al.  Regulators of G-Protein signalling as new central nervous system drug targets , 2002, Nature Reviews Drug Discovery.

[40]  Marco Siderius,et al.  Selectivity in overlapping MAP kinase cascades. , 2002, Journal of theoretical biology.

[41]  H. Dohlman,et al.  Pheromone-dependent Ubiquitination of the Mitogen-activated Protein Kinase Kinase Ste7* , 2002, The Journal of Biological Chemistry.

[42]  Reinhart Heinrich,et al.  Mathematical models of protein kinase signal transduction. , 2002, Molecular cell.

[43]  S. Hohmann Osmotic Stress Signaling and Osmoadaptation in Yeasts , 2002, Microbiology and Molecular Biology Reviews.

[44]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[45]  H. Dohlman Desensitization: Diminishing returns , 2002, Nature.

[46]  Prahlad T. Ram,et al.  G Protein Pathways , 2002, Science.

[47]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[48]  Katherine C. Chen,et al.  Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. , 2003, Current opinion in cell biology.

[49]  E. O’Shea,et al.  Global analysis of protein expression in yeast , 2003, Nature.

[50]  E. O’Shea,et al.  Global analysis of protein localization in budding yeast , 2003, Nature.

[51]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[52]  Necmettin Yildirim,et al.  Regulators of G Protein Signaling and Transient Activation of Signaling , 2003, Journal of Biological Chemistry.

[53]  B. Errede,et al.  Regulation of Ste7 Ubiquitination by Ste11 Phosphorylation and the Skp1-Cullin-F-box Complex* , 2003, Journal of Biological Chemistry.

[54]  J. Melo,et al.  Management of chronic myeloid leukemia: targets for molecular therapy. , 2003, Seminars in hematology.

[55]  H. Kitano,et al.  A quantitative characterization of the yeast heterotrimeric G protein cycle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  H. Dohlman,et al.  RGS proteins: G protein-coupled receptors meet their match. , 2003, Assay and drug development technologies.

[57]  Peter J Woolf,et al.  A Spatial Focusing Model for G Protein Signals , 2003, The Journal of Biological Chemistry.

[58]  Peter Uetz,et al.  The yeast G protein alpha subunit Gpa1 transmits a signal through an RNA binding effector protein Scp160. , 2003, Molecular cell.

[59]  T. Kenakin Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.

[60]  Shankar Subramaniam,et al.  Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[61]  B. Kholodenko,et al.  Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.

[62]  Edda Klipp,et al.  Modelling the dynamics of the yeast pheromone pathway , 2004, Yeast.

[63]  Keisuke Kuida,et al.  Inhibitors of Protein Kinase Signaling Pathways: Emerging Therapies for Cardiovascular Disease , 2004, Circulation.

[64]  R. Lefkowitz,et al.  Seven-Transmembrane Receptor Signaling Through β-Arrestin , 2005, Science's STKE.

[65]  Phosphorylation of the RGS protein Sst2 by the MAP kinase Fus3 and use of Sst2 as a model to analyze determinants of substrate sequence specificity. , 2005, Biochemistry.

[66]  H. Dohlman,et al.  MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. , 2005, Current opinion in chemical biology.

[67]  R. Lefkowitz,et al.  Seven-transmembrane receptor signaling through beta-arrestin. , 2005, Science's STKE : signal transduction knowledge environment.

[68]  Xiufen Zou,et al.  A theoretical framework for specificity in cell signaling , 2005, Molecular systems biology.

[69]  César Nombela,et al.  Protein phosphatases in MAPK signalling: we keep learning from yeast , 2005, Molecular microbiology.

[70]  Mark Gerstein,et al.  Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. , 2005, Genes & development.

[71]  Jan Lankelma,et al.  Principles behind the multifarious control of signal transduction , 2004, The FEBS journal.

[72]  E. Klipp,et al.  Integrative model of the response of yeast to osmotic shock , 2005, Nature Biotechnology.

[73]  Shinya Kuroda,et al.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.

[74]  H. Dohlman,et al.  Activation of the Phosphatidylinositol 3-Kinase Vps34 by a G Protein α Subunit at the Endosome , 2006, Cell.

[75]  T. Elston,et al.  Bistability, stochasticity, and oscillations in the mitogen-activated protein kinase cascade. , 2006, Biophysical journal.

[76]  Wen Zheng,et al.  Dynamic studies of scaffold-dependent mating pathway in yeast. , 2006, Biophysical journal.

[77]  Uri Alon,et al.  An Introduction to Systems Biology , 2006 .

[78]  J. Sebolt-Leopold,et al.  Mechanisms of drug inhibition of signalling molecules , 2006, Nature.

[79]  H. Dohlman,et al.  Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome. , 2006, Cell.

[80]  N. Hao,et al.  Genome-Scale Analysis Reveals Sst2 as the Principal Regulator of Mating Pheromone Signaling in the Yeast Saccharomyces cerevisiae , 2006, Eukaryotic Cell.

[81]  Axel Kowald,et al.  A modelling approach to quantify dynamic crosstalk between the pheromone and the starvation pathway in baker's yeast , 2006, The FEBS journal.

[82]  Christoph H. Borchers,et al.  A Systems-Biology Analysis of Feedback Inhibition in the Sho1 Osmotic-Stress-Response Pathway , 2007, Current Biology.

[83]  James E. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2007, Nature.

[84]  R. Neubig,et al.  Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay , 2007, Molecular Pharmacology.

[85]  S. Véronneau,et al.  Signal-Regulated Kinase Activation Mobilization and Extracellular Platelet-Activating Factor-Mediated Calcium Caveolae Facilitate but Are Not Essential for , 2009 .

[86]  D V Glass Diminishing returns. , The Eugenics review.

[87]  E. Wimmer,et al.  MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network , 2022 .